Quality of Reporting of Randomized Controlled Trials in Chiropractic using the CONSORT Checklist: A protocol for a review

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Jan 30, 2016
Fay Karpouzis

Abstract

Background: Despite the introduction of the CONSORT checklist, the quality of reporting of randomized controlled trials (RCTs) within the biomedical literature has been described as suboptimal, with a need for improvement, while that of chiropractic trials remains unexamined.Aims: The aim of this protocol is to develop a tool to assess the overall reporting quality of published chiropractic RCTs using standardised guidelines (i.e. CONSORT), to identify key methodological items that safeguard against biases and to identify predictors of better reporting quality.Methods/Design: A search of RCTs published in English from 2005 - 2014 will be performed in the international clinical trial registers, PubMed and the Cochrane library using keywords and Medical Subject Headings (MeSH). Trials will be included if they involve high-velocity low-amplitude spinal or extremity manipulation and are conducted by a chiropractor or within a chiropractic department/institution. RCTs meeting inclusion criteria will be assessed using a customised 39-point rating tool, designed by the authors. The customised tool will be based on the CONSORT 2010 and CONSORT for Non-Pharmacological Treatments statements. Furthermore, each RCT will be assessed according to 4 key methodological items (KMIS); allocation concealment; blinding of participants; blinding of assessors; and the use of intention-to-treat analysis (ITT). Predictors that will be chosen for the study, will be identified in the medical literature as influencing the reporting quality of RCTs such as: industry funding, positive findings, sample size, year of publication and journal type. A multiple regression analyses will be used to explore associations between the outcome, overall quality of reporting score (OQRS) and the predictor variables.Discussion: The results of this study will provide an OQRS in chiropractic RCTs over the last decade. It will provide an individual score for each item of the CONSORT 2010 and CONSORT for Non-Pharmacological Treatments checklists, as well as key methodological items. Furthermore, the study will provide a list of predictors for improved overall quality of reporting of chiropractic RCTs.
Abstract 244 | Quality of Reporting Downloads 105

##plugins.themes.bootstrap3.article.details##

Keywords

Manipulation, Chiropractic, Spinal Manipulative Therapy, Spine, Musculoskeletal, Quality of Reporting, Randomized Controlled Trials, The CONSORT Statement

References
1. Keech A, Gebski V, Pike R. Interpreting and Reporting Clinical Trials. A guide to the CONSORT statement and the principles of randomised controlled trials. Sydney: MJA Books, Australasian Medical Publishing Company; 2007
2. Moher D, Jones A, Lepage L, for the CONSORT Group. Use of the CONSORT Statement and Quality of Reports of Randomised Trials: A Comparative Before-and After-Evaluation. JAMA 2001;285(15):1992-5
3. Altman D, Schulz K, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134(8):663-94
4. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomised controlled trials: the CONSORT statement JAMA 1996;276(8):637-9
5. Tiruvoipati R, Balasubramanian SP, Atturu G, Peek GJ, Elbourne D. Improving the quality of reporting randomized controlled trials in cardiothoracic surgery: The way forward. J Thoracic Cardiovascular Surg 2006;132(2):233-40. doi: 10.1016/j.jtcvs.2005.10.056.
6. Partsinevelou A, Zintzaras E. Quality of reporting of randomized controlled trials in polycystic ovary syndrome. Trials 2009;10(106)
7. Chen B, Liu J, Zhang C, Li M. A retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndrome. Trials 2014;15(128)
8. Kim KH, Kang uW, Lee MS, Lee J-D. Assessment of the quality of reporting for treatment components in Cochrane reviews of acupuncture. BMJ Open 2014;4(e004136). doi: 10.1136/bmjopen-2013-004136
9. Rios LP, Odueyungbo A, Moitri MO, Rahman MO, Thabane L. Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinology Metabolism 2008;93:3810-16
10. Zhuang L, He J, Zhuang X, Lu L. Quality of reporting on randomized controlled trials of acupuncture for stroke rehabilitation. BMC Compl Altern Med 2014;14(151)
11. DeMauro SB, Giaccone A, Kirpalani H, Schmidt B. Quality of reporting of neonatal and infant trials in high-impact journals. Pediatrics 2011;128(e639)
12. Montori VM, Alonso-Coello P, Wang YG, Bhagra S. Systematic evaluation of the quality of randomized controlled trials in diabetes. Diabetes Care 2006;29(8):1833-38. doi: 10.2337/dc06-0077
13. Moberg-Mogren E, Nelson DL. Evaluating the quality of reporting occupational therapy randomized controlled trials by expanding the CONSORT criteria. Am J Occup Ther 2006;60(2):226–35
14. Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol. 2000;136(3):381-5. PubMed Central PMCID: PMC 10724201.
15. Moher D, Schulz KF, Altman D for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. BMC Med Res Method 2001;1(2).
16. Schulz KF, Altman DG, Moher D, Group ftC. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Br Med J 2010;340(c332):698-702. doi: doi: 10.1136/bmj.c332
17. Campbell MK, Piaggio G, Elbourne DR, Altman DG, for the CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. Br Med J 2012;345:e5661. PMID: 22951546
18. Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials. Extension of the CONSORT 2010 statement. JAMA 2012;308 (24):2594-604. doi: 10.1001/jama.2012.87802. PMID: 23268518
19. Zwarenstein M, Treweek S, Gagnier J, Altman D, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Br Med J 2008;337(a2390)
20. Gagnier J, Boon H, Rochon P, Barnes J, Moher D, Bombardier C, et al. Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected].[Erratum appears in Explore (NY). 2006 Jul-Aug;2(4):293]. Explore (NY) 2006;2(2):143-9. PubMed PMID: 16781628
21. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P for the CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatments: explanation and elaboration. Ann Intern Med 2008;148:295-309
22. MacPherson H, Altman D, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Medicine / Public Library of Science 2010;27(6):e1000261 PMID: 20543992
23. Calvert M, Blazeby J, Altman D, Revicki D, Moher D, Brundage MD, et al. Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO Extension. JAMA 2013;309(8):814-22 PMID: 23443445. doi: 10.1001/jama.2013.879
24. Ioannidis J, Evans S, Gotzsche P, O'Neill R, Altman D, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141(10):781-8 PMID: 15545678
25. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Medicine 2008;5(1):0048-56
26. Péron J. Quality of reporting of modern randomized controlledtrials in medical oncology: a systematic review. J National Cancer Institute 2012;104(13):982-9. doi: 10.1093/jnci/djs259
27. Lu L, Luo G, Xiao F. A retrospective survey of the quality of reports and their correlates among randomised controlled trials of immunotherapy for Guillian-Barre syndrome. Immunotherapy 2013;5(8):829-36. doi: 10.2217/imt.13.75
28. Borg-Debono V, Zhang S, Ye C, Paul J, Arya A, Hurlburt L, et al. The quality of reporting of RCTs used within a postoperative pain management meta-analysis, using the CONSORT statement. BMC Anesthesiology 2012;12(13)
29. Bo C, Xue Z, Yoi G, Zelin C, Yang B, Zixu W, et al. Assessing the quality of reports about randomized controlled trials of acupuncture treatment on diabetic peripheral neuropathy. Plos ONE 2012;7(7):e38461. doi: 10.1371/journal.pone.0038461
30. Sjögren P, Halling A. Quality of reporting randomised clinical trials in dental and medical research. Br Dent J 2002;192(2):100-4
31. Rubinstein SM, Terwee CB, de Boer MR, van Tulder MW. Is the methodological quality of trials on spinal manipulative therapy for low-back pain improving? International J Osteop Med 2012;15:37-52. doi: 10.1016/j.ijosm.2012.02.001
32. Rubinstein SM, van Eekelen R, Oosterhuis T, de Boer MR, Ostelo RWJG, van Tulder MW. The risk of bias and sample size of trials of spinal manipulative therapy for low back and neck pain: analysis and recommendations. J Manipulative Physiol Ther 2014;37(8):523-41.
33. Piggott M, McGee H, Feuer D. Has CONSORT improved the reporting of randomized controlled trials in the palliative care literature? A systematic review. Palliat Med 2004;18(1):32-8. doi: 10.1191/0269216304pm857oa
34. Lai R, Chu R, Fraumeni M, Thabane L. Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol 2006;24(7):1136-44
35. Bhandari M, Richards RR, Sprague S, Schemitsch EH. the quality of reporting of randomized trials in The Journal of Bone and Joint Surgery from 1988 through 2000. J Bone Joint Surg (Am) 2002;84(3):388 -96
36. Huwiler-Muntener K, Juni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002;287(21):2801–4
37. Boutron I, Moher D, Altman D, Schulz K, Ravaud P, for the CONSORT Group. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments: explanation and elaboration. Ann Intern Med 2008;148(4):295-309
38. Ntala C, Birmpili P, Worth A, Anderson NH, Sheikh A. The quality of reporting of randomised controlled trials in asthma: systematic review protocol. Primary Care Resp J 2013;22(1):PS1-PS8. doi: 10.4104/pcrj.2013.00003
39. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R et al.I Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004;292(1):1363-4
40. Moher D, Schulz K, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-91
Section
Articles